Related Experiment Video
Updated: Mar 1, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
A commentary on the pathogenesis of pertussis
1Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville 22908, USA. eh2v@virginia.edu
Research on Bordetella pertussis virulence factors is extensive, leading to new vaccines. However, understanding the pathogenesis of pertussis disease in humans remains limited, hindering effective treatment.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Extensive research has elucidated Bordetella pertussis virulence factors, their regulation, and mechanisms.
- Numerous studies have mutated or deleted genes for B. pertussis virulence components.
- Acellular vaccines targeting these virulence factors are available for pertussis prevention.
Purpose of the Study:
- To highlight the significant knowledge gap regarding the pathogenesis of Bordetella pertussis infection in humans.
- To emphasize the need for further research into human pertussis disease processes.
Main Methods:
- Literature review on Bordetella pertussis virulence factors and vaccines.
- Analysis of existing studies on B. pertussis gene mutations and deletions.
- Identification of research focusing on the human disease aspect.
Main Results:
- While virulence factors and vaccine development are well-documented, specific data on human pathogenesis is scarce.
- The molecular basis of disease progression in humans is not well understood.
Conclusions:
- Further investigation into the pathogenesis of Bordetella pertussis in humans is crucial.
- Enhanced understanding is necessary for improved diagnosis and treatment strategies for pertussis.
More Related Videos
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...